Kick off the Global Ethics Summit by spending time with your industry peers discussing best practices, challenges, and successes that specifically pertain to compliance in the healthcare industry.

This session, led by Morrison Foerster partners Kate Driscoll and James Koukios, examines the rapidly evolving DOJ enforcement landscape in life sciences and healthcare. In 2025, False Claims Act recoveries exceeded a record $6.8 billion, with whistleblower-driven cases surpassing government-initiated actions for the first time. We will explore emerging enforcement priorities, including criminal prosecution of digital health and telemedicine fraud, transnational organized crime, expanded criminal Anti-Kickback Statute theories, and DOJ’s aggressive use of the False Claims Act for both billing fraud and regulatory violations. The discussion will conclude with practical strategies to help organizations manage escalating civil and criminal enforcement risk and build resilient compliance programs in this high-stakes environment.

This discussion, led by Northwell Health’s Greg Radinsky, will cover a range of topics, including resources and reporting structure, Dept. of Justice enforcement, privacy breaches, artificial intelligence, structuring investigations, and reporting to the board of directors.